Erythromycin Capsule, Delayed Release
Product Images NDC 24338-120

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 24338-120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Arbor Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Erythromycin 01)

Chemical structure of erythromycin, showing its macrolide ring and attached functional groups, as presented in the product labeling for erythromycin capsules, delayed release.*

FDA Label Image

Principal Display Panel (250 mg Bottle Label)

ERYTHROMYCIN delayed-release capsules, USP, 250 mg, bottle label showing 100 capsules. The label includes the product NDC 24338-120-13, manufacturer Arbor Pharmaceuticals, Inc., and storage instructions. Capsules are maroon and clear with yellow and pink particles, marked with letters ER for identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.